Anti-Aging
Ventfort
Vascular-endothelium bioregulator peptide from the Khavinson short-peptide family.
- Route
- Subcutaneous, oral capsule
Overview
Ventfort (Lys-Glu-Asp-Ala) is claimed by its developers to support endothelial function and vascular ageing.
Mechanism of action
Hypothesised gene-expression modulation in endothelial cells, promoting nitric-oxide production and reducing oxidative stress.
Evidence base
Almost exclusively Russian clinical and preclinical work. No independent Western trials.
Typical dosing
Common protocol: 1–2 mg subcutaneously daily in 10–20 day cycles, 1–2 courses per year. Open the dose calculator →
Safety & contraindications
Reported well tolerated. Independent safety data are limited.
Related peptides
Educational reference only. Nothing on this page is medical advice, a prescription, or an offer to sell. Discuss any peptide therapy with a qualified clinician who can evaluate your history and monitoring needs.